GUS PLC
25 November 2005
GUS PLC
('THE COMPANY')
DIRECTOR/PDMR SHAREHOLDING
The Company has been advised by Abacus Corporate Trustee Limited ('Abacus') that
Abacus, as trustee of the GUS plc ESOP Trust, holds 12,986,187 Ordinary shares
of 25p each in the Company at today's date. The holding announced on 4 October
2005 of 14,079,751 shares included 1,018,813 shares held in a nominee account
(in respect of invested shares awarded to UK employees in accordance with the
terms of the Company's Co-investment Plan) and these shares are now excluded for
the purposes of these announcements. Since that date:
• On 3 November 2005, 489 shares were transferred to a nominee on behalf of a
participant in the Company's Co-investment Plan; and
• During the period from 10 October to 23 November, 74,262 shares have been
released in connection with the exercise of options granted under The North
America Stock Option Plan.
Directors of the Company are potential beneficiaries of this ESOP and
accordingly any changes in the shareholdings by the Trust are deemed to change
their interests in the Ordinary share capital of the Company.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.